Introduction
Pseudo-Hurler polydyslrophy (pseudopolydystrophy) is an inherited disorder exhibiting some of the features of both the mucopolysaccharidoses and the sphingolipidoses; hence, its recent designation as mucolipidosis III [16] .
The clinical features of this disorder include the following: joint stiffness associated wilh limitation of mobility, corneal opacities by slit lamp examination, mild skeletal abnormalities, minimal to moderate coarseness of facial features, mild mental retardation, and normal mucopolysaccharide excretion [8, 9, 13, 17] .
Although the palhogcnesis of this disorder remains obscure, the demonstration of vacuolated bone marrow cells [8] , gross alterations in the ultrastnicture of direct connective tissue cells [11] , and the presence of inclusion cells associated with gross ullrastructure changes in cultured fibroblasts [19] suggests that mucolipidosis III may be a "storage disorder" associated with abnormal lysosomal function.
In support of this suggestion, the findings reported here also indicate that there are marked alterations in a number of lysosomal enzyme activities in the serum and the fibroblast cells obtained from mucolipidosis III patients. In addition, evidence is presented which shows that these changes in en/.yme activity are very similar to those seen in mucolipidosis II (I-cell disease)
Materials and Methods

Patients
The four patients with the clinical features of mucolipidosis III included in tin's report were studied by the division of Medical Genetics of The Johns Hopkins Hospital [22] .
These [9, 13, 15] .
In addition, cultured fibroblast cells and serum from a patient with mucolipidosis 11 were included in this study for the purpose of comparison. The clinical, biochemical, and ultrastructural findings in this patient are described elsewhere [5, 7, 14] .
Methods
Fibroblast cells were cultured from skin biopsies obtained from the patients and the normal subjects as described elsewhere [19] . All cultures were harvested with trypsin and analyzed 7 days after subculture, and, when possible, were matched for total "culture age." 2), and centrifuged. The washed pellet was suspended in 3 ml distilled water and the cells were disrupted by ultrasonication. Extracts to be used for electrophoretic analysis were then centrifuged for 10 min at 5,000 x g at 3-5°. For direct en/.yme analysis, however, the centrifugation step was found to be unnecessary and was, therefore, omitted.
Serum samples were obtained in the usual manner and frozen until needed.
Both the total and the heat labile fractions of the A r -acetyl-/J-glucosaminidase activity were measured according to the method of Kaback [4] as described elsewhere [7] . The electrophoretic analysis was performed on Cellogel [24] strips (7.8 cm x 15 cm X 500 ^m) in 0.035 M citric acid-sodium citrate buffer pH 5.5 for 2.5 hr at 9.5-12.5 ma (approximate voltage ± 150) at room temperature according to the procedure of Rattazzi and Davidson [12] . The fluorescence of the enzyme product was enhanced by the substitution of ammonia vapors for the formol and glycine-carbonate treatments of the original procedure.
Arylsulfatase A activity was measured by a modification of the method of Baura et al. [1] . This consisted of incubating 0.2 ml serum or cell extract with 0.3 ml distilled water and 0.5 ml reagent A (0.01 M p-nitrocatechol sulfate in 0.5 M sodium acetate-acetic acid buffer which contained 5 X 10^4 M sodium pyrophosphate and 10% sodium chloride, pH 5.0) for 1 hr at 37°. At the end of this time 1.5 ml 1 N NaOH were added and the absorbance was determined at 515 nm. Blank values were obtained by incubating the sample and reagent A in separate tubes before the addition of the 1 N NaOH.
The /?-galactosidase, iV-acetyl-/3-glucosaminidase, afucosidase, and ct-mannosidase activities in the cultured fibroblast cells were determined spectrophotometrically by measuring the free p-nitrophenol released from the appropriate glycosidic derivatives dissolved in distilled water under the conditions given in Table I . After incubation at 37° for the appropriate period of time, the reactions were terminated by the addition of 0.4 ml 0.25 M glycine-carbonate buffer, pH 10, and the optical density was measured at 400 nm. All reactions were run in duplicate with the appropriate controls.
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The serum /3-galactosidase activity was determined by incubating 0.1 ml serum with 0.4 ml 4-methylumbelliferyl-/?-D-galactopyranoside (2 mM in citrate-phosphate buffer, pH 3.2) for 30 min at 37°. At the end of this time, 0.1 ml of the above solution was added to 2.5 ml 0.1 M 2-amino-2-methyl-l-propanol-HCl buffer, pH 10.3, and the fluorescence was determined.
The serum a-fucosidase activity was determined by a modification (0.9 ml glycine-carbonate buffer in the final step and determination of absorbance at 400 nm) of the method of Zielke et al. [21] .
Results
Each of the five lysosomal enzyme activities measured in the extracts of cultured fibroblast cells, obtained from the mucolipidosis III patients 2-4 (except a-fucosidase in patients 2 and 3), were found to be greatly reduced (Table II) . It was also found that, although there was a generalized reduction in the enzyme activities in the fibroblast cells from patient 1, the decrease was less marked than that found in the other mucolipidosis III patients and in several cases was very close to the low normal values.
In contrast to the decreased values in the fibroblast extracts, each of the enzymes measured in serum samples obtained from the same patients were increased several times that of the normal values (Tables III and  IV) .
As can be seen from the results given in Tables II  and III , the changes found in the fibroblast extracts and the serum samples from the mucolipidosis patients 2^f were very similar to those found in the patient with mucolipidosis II (I-cell disease).
A detailed analysis of the heat stability of one of these enzymes (A L acetyl-/3-D-glucosaminidase), utilizing the 4-methylumbelliferyl-A r -acetyl-/3-D-glucosaminide substrate, was also carried out. As is shown in Table  IV , only 19-24% of the total activity in the serum from the mucolipidosis III patients was destroyed by heating for 2 hr at 52°. This compares with an average value of 55% inactivation for serum from normal control subjects when treated in an identical manner.
An electrophoretic analysis of this enzyme in serum demonstrated the presence of two distinct bands of activity. Except for the marked increase in activity, these bands appeared to be identical with the faster moving bands (A and I 2 [25] ) routinely seen in normal serum samples (Fig. 1) [10] . In these samples, however, the I 2 band, not the A band, accounted for the major proportion of the activity. 1 Nanomoles of 4-methylumbelliferone released by I ml serum/ hr at 37°. 2 Nanomoles of ^-nitrophenol released by 1 ml serum/hr at 37°. 3 Nanomoles of nitrocatechol released by 1 ml serum/ hr at 37°. A similar analysis carried out on extracts of the fibroblast cells from the mucolipidosis III patients 2-4 yielded results for the heat stability of the iV-acetyl-/3-D-glucosaminidase which were similar to those obtained in extracts of normal fibroblast cells (Table V) . In contrast, the results obtained on the cells from mucolipidosis patient 1 were repeatedly abnormal with only 20% of the enzyme being destroyed by heating for 2 hr at 52°. In contrast with the two bands routinely detected in normal cell extracts, an electrophoretic analysis of the fibroblast extracts from patients 2-4 repeatedly yielded at least three distinct bands of activity (Fig. 1) . In each of these extracts the extra band moved between the two bands whose electrophoretic mobilities were identical with those seen in normal control subjects and were considered to represent the A and B bands (Fig. 1) .
In patient 1 the pattern was characterized, not only by the presence of the intermediate band, but also by a very marked increase in the relative amount of the slowest moving (B) band (Fig. 1) .
Discussion
We have found evidence previously which indicates that the "I-cell phenomenon" generally considered to be a unique feature of mucolipidosis II (I-cell disease) is also a characteristic feature of cultured fibroblast cells obtained from mucolipidosis III patients [19] .
The findings reported here show that patients with these two disorders also have in common a number of biochemical alterations involving a variety of lysosomal enzymes. Specifically, extracts of cultured fibroblast cells obtained from three of four patients with the clinical features of mucolipidosis III had a multiple enzyme deficiency very similar to that found in mucolipidosis 11 [6] . Moreover, as is the case in mucolipidosis II [20] , there were marked increases in a number of lysosomal enzymes in serum samples from the same patients.
Also in agreement with the data obtained from study of a mucolipidosis II patient [7] , is the finding that the increase (7-16 times normal) in the serum A r -acetyl-/3-D-glucosaminidase level was most prominent in the I 2 band (11-29 times normal).
This alteration in the ratio of the A activity to the 1 2 activity is believed to be the basis for the abnormal enzyme heat stability noted in the serum. This belief is based on the observation that the I 2 activity is stable under the conditions employed for the heat denaturation determination while the A activity is destroyed [10] .
Yet another similarity is the observation that the decreased iV-acetyl-/3-D-glucosaminidase acitivity in the fibroblast extracts in both disorders is associated with an abnormal electrophoretic pattern [7] . In mucolipidosis III, however, the pattern differed from the pattern found in mucolipidosis II [7] .
As discussed elsewhere [7] , the abnormal electrophoretic pattern could be caused by any one of several mechanisms and at the present time the actual significance of this observation is obscure. The absence, however, of similar electrophoretic changes in the serum samples from the patients, as well as several from the parents studied, suggests that this is not due to inherited changes in the primary amino acid composition of the enzyme.
It is of note, however, that preliminary studies carried out on the parents of these patients indicate that the percentage of the heat labile (A) fraction of the iV-acetyl-^-D-glucosaminidase is decreased in serum. An electrophoretic analysis of these samples, however, indicates that this alteration in ratio is due to an increase in the relative concentration of the heat stable I 2 rather than an absolute decrease in the A fraction. As with the patients, no aberrant bands were noted in the serum of these parents. A detailed analysis of both serum and fibroblast cells from this group of parents is currently underway.
Patient 1, who also had the clinical features of mucolipidosis III, was also found to have abnormal biochemical changes; however, in many cases these changes differed in either quantity or quality from those found in the other three patients. The basis for these differences is not understood; however, they are in keeping with the finding that the cytologic and ultrastructural changes in this patient are less dramatic than those of the other three patients [19] . These observations have led to the suggestion that this could be due to genetic variability or heterogeneity [19] . It is also possible that this patient represents an entirely different biochemical disorder which is very similar clinically to mucolipidosis III. Additional studies based on both biochemical and clinical findings should help clarify this question.
In summary, although mucolipidosis II and mucolipidosis III are clearly distinct disorders, they have very similar morphologic and biochemical alterations at the cellular level, and thus the nature of the defect may be very similar. It is, therefore, possible that the various hypotheses which have been proposed to explain the pathogenesis of mucolipidosis II (I-cell disease), i.e., cellular leakage [20] or defective site recognition [3] may also be of relevance in mucolipidosis III.
Summary
Five lysosomal enzymes were measured in fibroblast extracts and serum samples from four patients with mucolipidosis III. A multiple deficiency of several enzyme activities was found in the fibroblast cells obtained from three of these four patients which was very similar to that seen in mucolipidosis II (I-cell disease). In contrast, the serum levels of these same enzyme activities were greatly increased; this was again very similar to those levels found in mucolipidosis II.
The increased serum activity of one of these enzymes (IV-acetyl-/3-glucosaminidase) resided in two electrophoretic bands with the characteristics of the A and I 2 bands found in normal control serum. In contrast, the decreased level of this enzyme activity in fibroblast extracts was associated with an abnormal electrophoretic pattern.
